Paper Review Records
All Paper Review Records
25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
78
days
From molecular pathogenesis to novel Therapeutic approaches - a review of recent advances in the treatment of peripheral T cell Lymphomas
Authors
Wee Lee Chan; Wee Joo Chng; Qi-Jing LiShow moreShow less
Affiliations
1. Department of Haematology-Oncology, National University Cancer Institute Singapore, National University Hospital, National University Health System, Singapore, Singapore; 2. Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research, Singapore (A*STAR), Singapore, Singapore; 3. NUS Centre for Cancer Research (N2CR), 14 Medical Drive, Centre for Translational Medicine, Singapore, Singapore; 4. Cancer Science Institute of Singapore, National University of Singapore, Singapore, SingaporeShow moreShow less
58
days
HIRA loss is frequent but not universal in human fumarate hydratase-deficient renal cell carcinoma and defines divergent oncogenic programs
Authors
Xu Shi; Zehua Tan; Guangxi Sun; Hao Zeng; Xingming ZhangShow moreShow less
Affiliations
1. Department of Urology, Institute of Urology, Sichuan Clinical Research Center for Kidney and Urologic Diseases, West China Hospital, Sichuan University, Chengdu, ChinaShow moreShow less
119
days
Multidimensional 5-hydroxymethylcytosine features in cell-free DNA enable the detection, staging and subtyping of pancreatic ductal adenocarcinoma
Authors
Haoyu Shi; Cheng Qin; Yutong Zhao; Lirui Huang; Zeru Li; Tianyu Li; Bangbo Zhao; Weibin WangShow moreShow less
Affiliations
1. Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 2. Key Laboratory of Research in Pancreatic Tumor, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 3. National Science and Technology Key Infrastructure on Translational Medicine, Peking Union Medical College Hospital, Beijing, People’s Republic of ChinaShow moreShow less
97
days
Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study
Authors
Gaku Yamamichi; Taigo Kato; Atsuki Matsukawa; Nanae Masunaga; Haruhiko Hirata; Jun Okuno; Norihiko Kawamura; Kei Kunimasa; Ikumi Seto; Takanori Kin; Kentaro Masuhiro; Shinya Sato; Shohei Myoba; Shinobu Ikeda; Takeshi Ujike; Yu Ishizuya; Takuji Hayashi; Yoshiyuki Yamamoto; Koji Hatano; Atsunari Kawashima; Yohei Miyagi; Motohide Uemura; Kazumi Nishino; Takahiro Nakayama; Masashi Nakayama; Yoshito Takeda; Kenzo Shimazu; Norio NonomuraShow moreShow less
Affiliations
1. Department of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan; 2. Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine, Suita, Japan; 3. Department of Respiratory Medicine and Clinical Immunology, The University of Osaka Graduate School of Medicine, Suita, Japan; 4. Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan; 5. Department of Urology, Osaka International Cancer Institute, Osaka, Japan; 6. Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan; 7. Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan; 8. Bioscience Division, Research and Development Department, Tosoh Corporation, Ayase, Japan; 9. Medical Center for Translational Research, Department of Medical Innovation, The University of Osaka Hospital, Suita, Japan; 10. Department of Urology, Osaka Rosai Hospital, Sakai, Japan; 11. Department of Urology, Iwase General Hospital, Sukagawa, Fukushima, Japan; 12. Department of Urology, Fukushima Medical University School of Medicine, Fukushima, JapanShow moreShow less
164
days
FECH, a novel metabolic target influencing CAR T-cell phenotype and function
Authors
Marsha Pellegrino; Simone Vespa; Illari Salvatori; Giang Dang Mac; Cristiana Valle; Valerio Secli; Sara Cairoli; Bianca Maria Goffredo; Matteo Caforio; Valentina Folgiero; Lokossou William Sanvi; Elisabetta Vulpis; Elena Ciampini; Marco Scarsella; Ezio Giorda; Ferdinando Chiaradonna; Manuela Giansanti; Francesca Nazio; Alberto Ferri; Francesco Cecconi; Silvia Campello; Enrico Velardi; Ignazio Caruana; Emmanuel de BillyShow moreShow less
Affiliations
1. Department of Onco-Hematology, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; 2. Laboratory for Cell and Gene Therapy, Department of Paediatrics, Stem Cell Transplantation and Cell Therapy, University Hospital Würzburg, Würzburg, Germany; 3. Santa Lucia Foundation, IRCCS, Rome, Italy; 4. National Research Council (CNR), Institute of Translational Pharmacology (IFT), Rome, Italy; 5. Bambino Gesù Children’s Hospital, Division of Metabolic Diseases and Drug Biology, IRCCS, Rome, Italy; 6. Department of Experimental Medicine (DIMES), University of Genova, Genova, Italy; 7. Department of Biology, University of Rome Tor Vergata, Rome, Italy; 8. Department of Basic Biotechnological Sciences, Intensive Care and Perioperative Clinics Research, Catholic University of the Sacred Heart, Rome, Italy; 9. Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; 10. Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy; 11. Innate Lymphoid Cells Unit, Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy; 12. Catholic University of the Sacred Heart, Rome, Italy; 13. Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; 14. Department of Pediatrics - Hematology, Oncology, Stem Cell Transplantation and Cell Therapy, University Hospital Würzburg, Würzburg, GermanyShow moreShow less
160
days
Biomarker implications of gene editing in hematologic diseases: latest updates from ASH 2025
Authors
Zezhou Zang; Wei Zheng; Ruirong Xu; Siyuan CuiShow moreShow less
Affiliations
1. Shandong University of Traditional Chinese Medicine, Jinan, China; 2. Department of Hematology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China; 3. Institute of Hematology, Shandong University of Traditional Chinese Medicine, Jinan, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days